← Open Payments lookup

AMANDA OSBORNE: Open Payments

NPI 1346548096 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$656 in 29 payments from 14 companies in 2025. Trend: 2023 $988 · 2024 $1,456 · 2025 $656

Food & beverage: $654Education: $2
CompanyPaymentsAmount
Mallinckrodt Hospital Products Inc.5$93
AstraZeneca Pharmaceuticals LP5$89
NxStage Medical, Inc.1$66
Fresenius USA Marketing, Inc.3$62
Novartis Pharmaceuticals Corporation2$56
Vifor Pharma, Inc.2$55
Otsuka America Pharmaceutical, Inc.2$53
Novo Nordisk Inc2$52
Amgen Inc.2$40
ANI Pharmaceuticals, Inc.1$27

Products named: FARXIGA, NXSTAGE SYSTEM ONE, VELPHORO, Veltassa, JYNARQUE, Ozempic, TERLIVAZ, ACTHAR.

Industry payments across MS — which companies pay providers there.